JAN 31, 2018 6:55 AM PST

Scientists Diagnose Rare Condition Affecting Vitamin B12 Processing

WRITTEN BY: Kara Marker

A new discovery is making scientists rethink everything they know about rare hereditary diseases. One genetic mechanism found to cause errors in vitamin B12 metabolism may also be responsible for causing more than 40 other rare diseases. From McGill University Health Centre, scientists report the details of this finding.

Representation of the chemical structure of vitamin B12.

Rare hereditary diseases only occur when someone inherits two recessive mutations, one copy from each parent… or not. In a small population of people with a rare disease characterized by an inability to process vitamin B12, scientists found that the condition can arise when there is just one mutation on a single copy of the gene.

“This can result in a serious genetic disease that can cause anemia, neuro-cognitive impairment, and even early death," explained lead author Dr. Jean-Louis Guéant.

The condition, called “cblC,” usually occurs when both copies of a gene called MMACHC are mutated. But researchers discovered an epigenetic mechanism called “epimutation” or “epi-cblC,” where two genes adjacent to MMACHC silence the non-mutated copy of the gene. Together, the mutation on one copy and the silencing of the other cause cblC.

"This epimutation observed in patients causes MMACHC to shut down and become inactive,” explained co-author Dr. David Rosenblatt. “This has the same effect as an actual mutation in the gene itself.”

Mutations affecting MMACHC is the most common of the inborn genetic errors of vitamin B12 metabolism. Inborn genetic errors are those that are inherited and prevent the body from effectively making energy out of food. Vitamin B12 promotes nervous system function and the creation of red blood cells. Foods like dairy products, eggs, red meat, chicken, fish, and shellfish are all sources of vitamin B12; the body cannot make it on its own.

Epigenetic mechanisms like “epi-cblC” can be caused by environmental factors like diet, stress, and exposure to toxins. Researchers from the present study have identified this mechanism in European and North American patients with the vitamin B12 disorder.

Rosenblatt believes that the same mechanism could be the cause of other diseases as well.

In the future, Guéant and the rest of the research team plan on investigating epimutations in individuals with all kinds of severe cases of rare diseases, looking for new ways to develop treatments.

The present study was published in the journal Nature Communications.

Sources: McGill University Health Centre, National Institutes of Health Office of Dietary Supplements

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 25, 2019
Clinical & Molecular DX
NOV 25, 2019
eRapid: molecular diagnostic power in the palm of your hand
We've heard lofty biotech promises in the news of being able to diagnose diseases from a single drop of blood. Yet, diag ...
DEC 23, 2019
Clinical & Molecular DX
DEC 23, 2019
Long awaited at-home test gives hemophiliacs peace of mind
Haemophilia is a genetically-inherited condition that severely affects an individual’s ability to stop bleeding. B ...
JAN 14, 2020
Clinical & Molecular DX
JAN 14, 2020
Can I eat this donut? A quick test for celiac disease.
Genetic testing revealed that our ancestors have been eating wheat, rye, spelt and barley for over 8,000 years. Today, g ...
APR 23, 2020
Clinical & Molecular DX
APR 23, 2020
FDA Approves At-Home Sample Collection Diagnostic Test for COVID-19
The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). M ...
MAY 14, 2020
Clinical & Molecular DX
MAY 14, 2020
New Tech Has Its AI on Brain Tumors
  A collaboration across 29 research and healthcare agencies is putting together the world’s largest brain tu ...
MAY 23, 2020
Microbiology
MAY 23, 2020
The FDA Yanks Some COVID-19 Antibody Tests From the Market
The massive demand for diagnostic testing led the FDA to open a short window for many testing products to go to market w ...
Loading Comments...